1-Oxoisoindolinverbindungen zur Behandlung von Spinaler Muskelatrophie und Andere Anwendungen
EP2027088
Art A2
25. Februar 2009
Anmelder: The United States of America, as represented by The Secretary, Department of Health and Human Services, Albany Molecular Research, Inc., Government of the United States of America, Represented by the Secretary, Department of Health and Human Services, SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP2027088
- Aktenzeichen
- EP07753404
- Anmeldetag
- 16. März 2007
- Veröffentlichung
- 25. Februar 2009
- Rechtsraum
- EP
- IPC
- C07D209/46C07D401/04C07D403/04C07D409/04
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The United States of America, as represented by The Secretary, Department of Health and Human Services
Albany Molecular Research, Inc.
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health - Land
- 🇺🇸 USA
🇺🇸
United States Department of Health and Human Services
US-Bundesministerium, das über seine Behörden (u.a. NIH) medizinische Forschung fördert und daraus resultierende Patente im Namen der US-Regierung hält.
967 Patente in unserer Datenbank